Status:
UNKNOWN
Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)
Lead Sponsor:
University of Birmingham
Conditions:
COVID-19
Coronavirus
Eligibility:
All Genders
Brief Summary
CovidSurg will capture real-world international data, to determine 30-day mortality in patients with COVID-19 infection who undergo surgery. This shared international experience will inform the manage...
Detailed Description
There is an urgent need to understand the outcomes of COVID-19 infected patients who undergo surgery. Capturing real-world data and sharing international experience will inform the management of this ...
Eligibility Criteria
Inclusion
- Patients undergoing ANY type of surgery in an operating theatre, this includes obstetrics
- AND
- \- The patient had COVID-19 infection either at the time of surgery or within 30 days of surgery, based on
- (i) positive COVID-19 lab test or computed tomography (CT) chest scan
- OR
- (ii) clinical diagnosis (no COVID-19 lab test or CT chest performed)
Exclusion
- If COVID-19 infection is diagnosed \>30 days after discharge, the patient should not be included.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04323644
Start Date
January 1 2020
End Date
September 30 2020
Last Update
May 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital del Henares
Madrid, Spain